Loading clinical trials...
Loading clinical trials...
A Phase II Trial of Losartan to Reverse Sickle Nephropathy
Conditions
Interventions
Losartan
Locations
9
United States
University of Illinois at Chicago
Chicago, Illinois, United States
University of Louisville
Louisville, Kentucky, United States
NHLBI
Bethesda, Maryland, United States
Akron Children's Hospital
Akron, Ohio, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
University of Cincinnati
Cincinnati, Ohio, United States
Start Date
February 1, 2012
Primary Completion Date
November 1, 2015
Completion Date
December 1, 2015
Last Updated
September 29, 2020
NCT06291376
NCT05797610
NCT06647979
NCT07163611
NCT07266181
NCT05505500
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions